Cargando…

Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group

BACKGROUND: This retrospective, single centre study was conducted to investigate the efficacy of fibrinogen concentrate (FBNc) in decreasing blood requirements and reaching optimal fibrinogen level, in non-trauma, massively transfused, bleeding patients with coagulopathy. METHODS: Over a 3-years per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leal-Noval, Santiago R, Casado, Manuel, Arellano-Orden, Victoria, Dusseck, Reginald, Bautista-Paloma, Javier, Muñoz, Manuel, Naranjo-Izorieta, José, Moreno, Antonio Puppo, Cayuela, Aurelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258800/ https://www.ncbi.nlm.nih.gov/pubmed/25489274 http://dx.doi.org/10.1186/1471-2253-14-109

Ejemplares similares

Is fibrinogen the answer to coagulopathy after massive transfusions?
por: Tisherman, Samuel A
Publicado: (2010)

Blood transfusion during cardiac surgery: massive transfusion coagulopathy
por: Trlaja, A, et al.
Publicado: (2013)

Transfusion massive et coagulopathie-: physiopathologie et implications cliniques
por: Hardy, Jean-François, et al.
Publicado: (2006)

Lactate and fibrinogen as good predictors of massive transfusion in postpartum hemorrhage
por: Okada, Asami, et al.
Publicado: (2019)

Bad blood: A coagulopathy associated with trauma and massive transfusion review
por: Vernon, Tawnya, et al.
Publicado: (2019)

Trauma-induced coagulopathy and critical bleeding: the role of plasma and platelet transfusion
por: Ishikura, Hiroyasu, et al.
Publicado: (2017)

Early Hypocalcemia in Severe Trauma: An Independent Risk Factor for Coagulopathy and Massive Transfusion
por: Vettorello, Marco, et al.
Publicado: (2022)

Analysis of transfusion requirements and costs before and after the introduction of thromboelastometry guided factor concentrate based algorithm for the therapy of coagulopathy in massive bleeding
por: Zykova, I, et al.
Publicado: (2015)

Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
por: Morrow, Gael B., et al.
Publicado: (2021)

Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion
por: Moore, Hunter B., et al.
Publicado: (2022)

Albumin and fibrinogen levels’ relation with orthopedics traumatic patients’ outcome after massive transfusion
por: Bazavar, Mohammadreza, et al.
Publicado: (2014)

Massive Gastrointestinal Bleeding Masquerading Coagulopathy in Acute Viral Hepatitis: A Case Report
por: Pokhrel, Bhishma, et al.
Publicado: (2020)

Fibrinogen in dilutional coagulopathy: a dose study in pigs
por: Martini, J, et al.
Publicado: (2010)

Association of Massive Transfusion for Resuscitation in Gastrointestinal Bleeding with Transfusion-related Acute Lung Injury
por: Case, James J., et al.
Publicado: (2017)

No impact of a massive transfusion protocol on coagulopathy and mortality at a level 1 trauma center: why?
por: Bourassa-Fulop, C, et al.
Publicado: (2012)

The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?
por: Barelli, Stefano, et al.
Publicado: (2018)

Massive transfusion and massive transfusion protocol
por: Patil, Vijaya, et al.
Publicado: (2014)

The shock index for pre-hospital identification of trauma patients with early acute coagulopathy and massive bleeding
por: Pasquier, Pierre, et al.
Publicado: (2015)

Changes in fibrinogen availability and utilization in an animal model of traumatic coagulopathy
por: Hagemo, Jostein S, et al.
Publicado: (2013)

Management of Coagulopathy in Bleeding Patients
por: Hofer, Stefan, et al.
Publicado: (2021)

Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study
por: Hagemo, Jostein S, et al.
Publicado: (2015)

Fibrinogen and base excess levels as predictive markers of the need for massive blood transfusion after blunt trauma
por: Umemura, Takehiro, et al.
Publicado: (2015)

Definitions of massive transfusion in adults with critical bleeding: a systematic review
por: Lin, Victor S., et al.
Publicado: (2023)

Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology
por: Oldroyd, J. C., et al.
Publicado: (2016)

Blood transfusion and coagulopathy in geriatric trauma patients
por: Mador, Brett, et al.
Publicado: (2017)

Effect of cell salvage on bleeding, transfusion of blood products, and bleeding parameters in patients undergoing liver transplantation with intraoperative massive blood transfusion
por: ULUDAĞ YANARAL, Tümay, et al.
Publicado: (2022)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy
por: Winstedt, DW, et al.
Publicado: (2013)

First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study
por: Innerhofer, Nicole, et al.
Publicado: (2021)

Red blood cell transfusion may be more detrimental than anemia for the clinical outcome of patients with severe traumatic brain injury
por: Leal-Noval, Santiago R., et al.
Publicado: (2019)

Dose-response of fibrinogen and factor XIII concentrate for correcting albumin-induced coagulopathy
por: Schött, US, et al.
Publicado: (2013)

Fibrinogen depletion in trauma: early, easy to estimate and central to trauma-induced coagulopathy
por: Davenport, Ross, et al.
Publicado: (2013)

Coagulopathy following major trauma hemorrhage: lytic, lethal and a lack of fibrinogen
por: Davenport, Ross
Publicado: (2014)

Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive study
por: Nair, Shalini, et al.
Publicado: (2016)

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012)

Prehospital identification of trauma patients with early acute coagulopathy and massive bleeding: results of a prospective non-interventional clinical trial evaluating the Trauma Induced Coagulopathy Clinical Score (TICCS)
por: Tonglet, Martin L, et al.
Publicado: (2014)

Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM
por: Winstedt, Dag, et al.
Publicado: (2014)

Massive transfusion practice
por: Campbell, M, et al.
Publicado: (2012)

Redefining massive transfusion
por: König, Thomas C, et al.
Publicado: (2009)

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients
por: Lissitchkov, Toshko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r95gi27m0v3g3vrjh1mfg2gu9n